Stock Analysis Report

Executive Summary

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally.



6 star dividend payer and good value.

Similar Companies

Share Price & News

How has Cardinal Health's share price performed over time and what events caused price changes?

Latest Share Price and Events

Market Performance

7 Day Return




US Healthcare


US Market

1 Year Return




US Healthcare


US Market

Return vs Industry: CAH matched the US Healthcare industry which returned -9.4% over the past year.

Return vs Market: CAH underperformed the US Market which returned 6.7% over the past year.

Share holder returns

7 Day2.9%0.6%1.0%
30 Day-2.7%-3.3%-1.8%
90 Day0.3%-8.9%-1.8%
1 Year-5.1%-8.9%-8.0%-9.4%9.1%6.7%
3 Year-30.9%-37.4%30.0%24.8%46.1%36.6%
5 Year-27.4%-36.7%60.1%50.5%66.9%48.6%

Price Volatility Vs. Market

How volatile is Cardinal Health's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Cardinal Health undervalued based on future cash flows and its price relative to the stock market?


Discount to future cash flow value

Intrinsic Value Based on Future Cash Flows

Undervalued: CAH ($46.92) is trading below our estimate of fair value ($69.56)

Significantly Undervalued: CAH is trading below fair value, but not by a significant amount.

Price Based on Earnings

PE vs Industry: CAH is good value based on its PE Ratio (10.3x) compared to the Healthcare industry average (19.9x).

PE vs Market: CAH is good value based on its PE Ratio (10.3x) compared to the US market (17.5x).

Price Based on Expected Growth

Low PEG Ratio: CAH is poor value based on its PEG Ratio (4.7x)

Price Based on Value of Assets

PB vs Industry: CAH is good value based on its PB Ratio (2.2x) compared to the US Healthcare industry average (2.4x).

Next Steps

Future Growth

How is Cardinal Health expected to perform in the next 1 to 3 years based on estimates from 15 analysts?


Forecasted annual earnings growth

Earnings and Revenue Growth Estimates

Future Annual Growth Analysis

Earnings vs Savings Rate: CAH's forecast earnings growth (2.2% per year) is below the savings rate (2.7%).

Earnings vs Market: CAH's earnings (2.2% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: CAH's earnings are forecast to grow, but not significantly.

Revenue vs Market: CAH's revenue (3.9% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: CAH's revenue (3.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Estimates

Future Return on Equity

High Future ROE: CAH's Return on Equity is forecast to be high in 3 years time (23.3%)

Next Steps

Past Performance

How has Cardinal Health performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Past Earnings Growth Analysis

Earnings Trend: CAH's earnings have declined by -10.7% per year over the past 5 years.

Accelerating Growth: CAH's earnings growth over the past year (432.4%) exceeds its 5-year average (-10.7% per year).

Earnings vs Industry: CAH earnings growth over the past year (432.4%) exceeded the Healthcare industry 5.3%.

Return on Equity

High ROE: Whilst CAH's Return on Equity (21.56%) is high, this metric is skewed due to their high level of debt.

Return on Assets

ROA vs Industry: CAH's Return on Assets is below or equal to the Healthcare industry average last year.

Return on Capital Employed

ROCE Improving: CAH's Return on Capital Employed has declined over the past 3 years.

Next Steps

Financial Health

How is Cardinal Health's financial position?

Financial Position Analysis

Short Term Liabilities: CAH's short term assets ($25.7B) exceeds its short term liabilities ($24.1B)

Long Term Liabilities: CAH's short term assets (25.7B) exceeds its long term liabilities (10.5B)

Debt to Equity History and Analysis

Debt Level: CAH's debt to equity ratio (126.9%) is considered high

Reducing Debt: CAH's debt to equity ratio has increased from 62.2% to 126.9% over the past 5 years.

Debt Coverage: CAH's debt is well covered by operating cash flow (33.9%).

Interest Coverage: CAH's interest payments on its debt are well covered by EBIT (6.1x coverage).

Balance Sheet

Inventory Level: CAH has a high level of physical assets or inventory.

Debt Coverage by Assets: CAH's debt is covered by short term assets (assets are 3.206350x debt).

Next Steps


What is Cardinal Health's current dividend yield, its reliability and sustainability?


Expected Dividend Yield

Dividend Yield vs Market


Current dividend yield vs market & industry

Dividend Yield and Payments Analysis

Notable Dividend: CAH's dividend (4.1%) is higher than the bottom 25% of dividend payers in the US market (1.46%).

High Dividend: CAH's dividend (4.1%) is in the top 25% of dividend payers in the US market (3.77%)

Stable Dividend: CAH's dividends per share have been stable in the past 10 years.

Growing Dividend: CAH's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (42%), CAH's dividend payments are well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: CAH's dividends in 3 years are forecast to be well covered by earnings (42% payout ratio).

Next Steps


What is the CEO of Cardinal Health's salary, the management and board of directors tenure and is there insider trading?


Average management tenure


Mike Kaufmann (56yo)





Mr. Michael C. Kaufmann, also known as Mike, has been the Chief Executive Officer and Director of Cardinal Health, Inc. since January 1, 2018. Mr. Kaufmann served as the Chief Financial Officer at Cardinal ...

CEO Compensation Analysis

Compensation vs. Market: Mike has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.

Compensation vs Earnings: Mike's compensation has increased by more than 20% in the past year.

Management Age and Tenure


Average Tenure


Average Age

Experienced Management: CAH's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Age and Tenure


Average Tenure


Average Age

Experienced Board: CAH's board of directors are considered experienced (5.1 years average tenure).

Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

SellUS$44,66213 Nov 18
Stuart Laws
Chief Accounting Officer
Senior VP & Chief Accounting Officer
Max PriceUS$56.05

Ownership Breakdown

Management Team

  • Victor Crawford (57yo)

    Chief Executive Officer of Pharmaceutical Segment

    • Tenure: 0.9yrs
    • Compensation: US$6.73m
  • Dave Evans (56yo)

    Interim Chief Financial Officer

    • Tenure: 0.08yrs
  • Mike Kaufmann (56yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: US$15.57m
  • Stuart Laws (56yo)

    Senior VP & Chief Accounting Officer

    • Tenure: 12.3yrs
  • Brian Rice (56yo)

    Chief Information Officer

    • Tenure: 0.7yrs
  • Ola Snow (52yo)

    Chief Human Resources Officer

    • Tenure: 1yrs
  • Jessica Mayer (50yo)

    Chief Legal & Compliance Officer

    • Tenure: 0.6yrs
    • Compensation: US$2.97m
  • Michele A. Holcomb (51yo)

    Executive Vice President of Strategy & Corporate Development

    • Tenure: 2.8yrs
  • Lisa Capodici

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Robert Rajalingam

    Senior Vice President of Strategic Accounts & Enterprise Marketing

    • Tenure: 0yrs

Board Members

  • Calvin Darden (69yo)

    Independent Director

    • Tenure: 13.9yrs
    • Compensation: US$288.25k
  • Carrie Cox (61yo)

    Independent Director

    • Tenure: 9.8yrs
    • Compensation: US$301.24k
  • Bruce Downey (72yo)

    Independent Director

    • Tenure: 10.2yrs
    • Compensation: US$303.25k
  • Gregory Kenny (66yo)

    Non-Executive Chairman

    • Tenure: 0.9yrs
    • Compensation: US$504.95k
  • Mike Losh (73yo)

    Independent Director

    • Tenure: 0.8yrs
    • Compensation: US$238.98k
  • Pat Hemingway Hall (66yo)

    Independent Director

    • Tenure: 6.1yrs
    • Compensation: US$287.99k
  • Mike Kaufmann (56yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: US$15.57m
  • Colleen Arnold (62yo)

    Independent Director

    • Tenure: 12.2yrs
    • Compensation: US$278.25k
  • Nancy Killefer (65yo)

    Independent Director

    • Tenure: 4.1yrs
    • Compensation: US$278.25k
  • Akhil Johri (58yo)

    Independent Director

    • Tenure: 1.7yrs
    • Compensation: US$397.83k

Company Information

Cardinal Health, Inc.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Cardinal Health, Inc.
  • Ticker: CAH
  • Exchange: NYSE
  • Founded: 1979
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$13.720b
  • Shares outstanding: 292.40m
  • Website: https://www.cardinalhealth.com

Number of Employees


  • Cardinal Health, Inc.
  • 7000 Cardinal Place
  • Dublin
  • Ohio
  • 43017
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CAHNYSE (New York Stock Exchange)YesClass A Common SharesUSUSDAug 1983
CLHDB (Deutsche Boerse AG)YesClass A Common SharesDEEURAug 1983
CAH *BMV (Bolsa Mexicana de Valores)YesClass A Common SharesMXMXNAug 1983
0HTGLSE (London Stock Exchange)YesClass A Common SharesGBUSDAug 1983


Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharma ...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 01:05
End of Day Share Price2019/10/11 00:00
Annual Earnings2019/06/30

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)